Kadri, Hachemi, Lambourne, Olivia A and Mehellou, Youcef ![]() |
Preview |
PDF
- Accepted Post-Print Version
Download (725kB) | Preview |
Abstract
Niclosamide is an anthelmintic drug that has mainly been used for over 50 years to treat tapeworm infections. However, with the increase in drug repurposing initiatives, niclosamide has emerged as a true hit in many screens against various diseases. Indeed, from being an anthelmintic drug, it has now shown potential in treating Parkinson's disease, diabetes, viral and microbial infections as well as various cancers. Such diverse pharmacological activities are a result of niclosamide's ability to uncouple mitochondrial phosphorylation and modulate a selection of signaling pathways, such as Wnt/β‐catenin, mTOR and JAK/STAT3, which are implicated many diseases. In this highlight, we will discuss the plethora of diseases that niclosamide has shown promise in treating.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Pharmacy |
Publisher: | Wiley-VCH Verlag |
ISSN: | 1860-7179 |
Date of First Compliant Deposit: | 10 April 2018 |
Date of Acceptance: | 29 March 2018 |
Last Modified: | 17 Nov 2024 10:30 |
URI: | https://orca.cardiff.ac.uk/id/eprint/110614 |
Citation Data
Cited 45 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |